A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma. Issue 10 (24th August 2022)

Record Type:
Journal Article
Title:
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma. Issue 10 (24th August 2022)
Main Title:
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
Authors:
Zhang, Qingyuan
Tao, Rong
Li, Zhenyu
Guo, Haiyi
Ji, Meng
Zhang, Lu
Huang, Jane
Lina, Fu
Zhong, Jinhua
Zhou, Jianfeng
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 63:Issue 10(2022)
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 10(2022)
Issue Display:
Volume 63, Issue 10 (2022)
Year:
2022
Volume:
63
Issue:
10
Issue Sort Value:
2022-0063-0010-0000
Page Start:
2503
Page End:
2506
Publication Date:
2022-08-24
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2022.2074985 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
24031.xml